Literature DB >> 6245

Haemodynamic effects of beta-adrenorecptor blockers in hypertension.

B Ablad, B Ljung, R Sannerstedt.   

Abstract

The haemodynamic effect pattern of beta-blockers in hypertension is discussed. The time curve of the antihypertensive effect differs from that of cardiac beta-blockade. The antihypertensive effect is characterized by a slower onset at the start of treatment and a more gradual disappearance when therapy is withdrawn. It appears that the crucial effect of beta-blockers in hypertension is a gradually developing reduction in total peripheral vascular resistance. The mechanism of this apparent vasodilator action is unknown. Various possible factors involved are mentioned. One is a reduced efficiency of transmitter release from the peripheral adrenergic neuron. Such an action may contribute to the antihypertensive effect, as judged by results of animal experiments described.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6245     DOI: 10.2165/00003495-197600111-00028

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  27 in total

1.  Impaired vasoconstrictor nerve function in spontaneously hypertensive rats after long-term treatment with propranolol and metroprolol.

Authors:  B Ljung; B Ablad; C Dahlöf; M Henning; E Hultberg
Journal:  Blood Vessels       Date:  1975

2.  Comparison between alprenolol and propranolol as antihypertensive agents. A double-blind cross-over study.

Authors:  C Bengtsson
Journal:  Acta Med Scand       Date:  1972-11

3.  Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.

Authors:  L Hansson; A J Zweifler; S Julius; S N Hunyor
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

4.  Antihypertensive therapy with alprenolol, a beta-adrenergic receptor antagonist.

Authors:  G Tibblin; B Ablad
Journal:  Acta Med Scand       Date:  1969-11

5.  Effect of propranolol on elevated arterial blood pressure.

Authors:  D W Richardson; J Freund; A S Gear; H P Mauck; L W Preston
Journal:  Circulation       Date:  1968-04       Impact factor: 29.690

6.  Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.

Authors:  L Hansson; H Aberg; S Jameson; B Karlberg; R Malmcrona
Journal:  Acta Med Scand       Date:  1973-12

7.  Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness.

Authors:  M D Esler; P J Nestel
Journal:  Br Heart J       Date:  1973-05

8.  Effect of acute and chronic treatment with practolol on cardiovascular responses in the pithed rat.

Authors:  M J Lewis
Journal:  J Pharm Pharmacol       Date:  1974-10       Impact factor: 3.765

9.  Propranolol in hypertension.

Authors:  B N Prichard; P M Gillam
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

10.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04
View more
  4 in total

1.  Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.

Authors:  J Tuomilehto; A Nissinen
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

2.  Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.

Authors:  C L van Herwaarden; R A Binkhorst; J F Fennis; A van't Laar
Journal:  Br Heart J       Date:  1979-01

3.  Acebutolol in hypertension--double-blind trial against placebo.

Authors:  M A Martin; C A Phillips; A J Smith
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

4.  Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.

Authors:  M M Kubik; J H Coote
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.